Supplemental information for "Biomarkers predictive of severe complications and mortality in patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid: a retrospective longitudinal observational study"

Name: Supplemental information for "Biomarkers predictive of severe complications and mortality in patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid: a retrospective longitudinal observational study"
Creator: Yumi Aoyama
Published: 2021-04-07T07:31:30.716Z
Keywords: Biomarkers, Autoimmune Disorder, Retrospective Study, Immune Response, Adverse Effect of Drug, Bullous Disease

Aoyama, Yumi; Sugiyama, Seiko; Yamamoto, Takenobu

doi:10.17632/cfdv85gmv5.1

Supplemental information for "Biomarkers predictive of severe complications and mortality in patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid: a retrospective longitudinal observational study"

Published: 07-04-2021| Version 1 | DOI: 10.17632/cfdv85gmv5.1

Contributors:

Yumi Aoyama,

Seiko Sugiyama,

Takenobu Yamamoto

Description

Contents: Supplemental Methods and Legends Supplemental Fig 1 Supplemental Fig 2 Supplemental Fig 3

Supplemental information for "Biomarkers predictive of severe complications and mortality in patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid: a retrospective longitudinal observational study"

Description

Files